Flagship Pioneering

Venture Capital Exempt reporting adviser

Legal name: Flagship Pioneering, LLC

Cambridge, MA Website LinkedIn

AUM

$13.4B
Private fund assets

Private funds

29
Venture Capital 29

Private fund assets

$13.4B
Gross asset value

Employees

—

Last Form D raise

Nov 2024
Most recent fund filing

From SEC Form ADV filing (filed Mar 31, 2026). View on SEC

Investment focus

As listed in industry directories; may be out of date.

Stages
Series A
Geographies
USA

People(1)

Owners and executive officers named on the firm's SEC Form ADV.

N
Member, Flagship Pioneering Futures

Funds(29)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Flagship Pioneering Fund VIII, L.P.Venture Capital$2.5B$2.6B109Nov 2024Cool
Flagship Pioneering Fund VII, L.P.Venture Capital$3.8B——Mar 2020Cold
Flagship Pioneering Special Opportunities Fund II, L.P.Venture Capital$642.7M$824.0M60Mar 2019Cold
Flagship Pioneering Fund VI, L.P.Venture Capital$1.4B$618.0M44Dec 2017Cold
Flagship Ventures Opportunities Fund I, L.P.Venture Capital$159.2M——Jun 2016Cold
Flagship Ventures Fund V, L.P.Venture Capital$334.7M——Dec 2014Cold
Flagship Venturelabs VI LLCVenture Capital$1.2B———
Flagship Labs VII LLCVenture Capital$610.2M———
Fpn III, L.P.Venture Capital$346.4M———
Fpa II, L.P.Venture Capital$279.9M———
Et FundVenture Capital$279.2M———
Fpa, L.P.Venture Capital$264.4M———
Fpn II, L.P.Venture Capital$261.1M———
Flagship Venturelabs V LLCVenture Capital$231.7M———
Flagship Ventures V Agricultural Fund, L.P.Venture Capital$185.8M———

Board seats(3)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Codiak BioSciences
BiotechnologyCambridge, MADirector: Noubar Afeyan
$31.0M raised
Since Nov 2015
SEC Form D
BG Medicine
BiotechnologyWaltham, MADirector: Noubar Afeyan
$500K raised
Since May 2015
SEC Form D
Moderna
PharmaceuticalsCambridge, MADirector: Noubar Afeyan
$581.1M raised
Since Jan 2014
SEC Form D

Regulatory identifiers

CRD number
161864
SEC file number
802-75749
CIK
1400240

Sources